Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
about
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancerTreatment including anthracyclines versus treatment not including anthracyclines for childhood cancerAcute lymphoblastic leukaemiaEffect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trialA randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaDevelopment of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemiaSafe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology GroupModifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407High-risk childhood acute lymphoblastic leukemiaThe Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.Outcomes for children and adolescents with cancer: challenges for the twenty-first century.Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.Blood consult: therapeutic strategy and complications in the adolescent and young adult with acute lymphoblastic leukemiaDeclining childhood and adolescent cancer mortalityA Gaussian Copula Model for Multivariate Survival DataCD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemiaImproved outcome in childhood ALL with intensive consolidation and hematopoietic stem cell transplantUse of appropriate initial treatment among adolescents and young adults with cancer.Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.Isolated central nervous system relapse of acute lymphoblastic leukemiaAugmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.Improved prognosis for older adolescents with acute lymphoblastic leukemia.Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology groupWeight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group.Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's OnAugmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.Treatment of pediatric acute lymphoblastic leukemia.Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).
P2860
Q24193790-36F1F109-7BCF-4418-897E-F1B23FFCC87CQ24234833-3DD6724D-E3F9-4BA1-8B1A-5CE7879A023BQ24602387-896C7AE9-2177-42E9-BA25-B51EEEEB5AC5Q24621523-CCFB61F3-F5E3-4E33-A550-5D4A6DE12F00Q24633382-041978F7-DBF9-4198-BC35-24A17529FC93Q26781328-1239553B-CA1D-485F-ACFD-21C402E366BBQ26825970-8E4B6D76-B902-4D4A-8D4C-C67EEC0E649DQ30300395-A708D12B-CAF0-4E62-AE2B-82A151F7E2B1Q30417943-45AB670B-4E67-4559-9DF8-13BA2F338621Q33559419-3137C865-341D-4C91-B232-84F543400C48Q33622837-528D880A-2084-4314-BC33-AD3678C0C223Q33632120-1595C1BE-9FFF-42A1-8CE6-FBFCD4C8C072Q33647130-268E4C4E-6708-45EB-83D1-73144334E8CAQ33711119-A9B63718-EE05-41B7-A7CB-3CEBACEFF906Q33762835-D70ED227-7E7D-4F39-8FF5-7277046700F8Q33888105-1CC586C3-3B0E-40A2-BA7A-8A70EBA61382Q33897659-1F97AA6F-E75F-4234-8BC2-ECCEF11E2596Q34003323-0503A60A-6AD0-4672-8B4A-5AE51BD1F6BBQ34009088-6C2D5545-4E07-4E53-8D24-3E338AB17DB8Q34060045-7AD14729-F2FB-440E-81C7-F932530CDB1EQ34097546-F4B296ED-3A05-4AFA-A7CE-6661F56043D8Q34165735-1EFF25E5-3F57-4BB7-B8EB-F60FBCEA6F88Q34316823-725D4CB6-7B56-4A5A-819C-9C9A714E8886Q34354175-9718FCC5-4DD8-42A4-97AD-A2D24651FB22Q34455093-09B838EC-65ED-4A9D-AEB9-17E13A12C69FQ34509402-4526FBAA-1A12-4873-939F-22348A3CE36AQ34550540-73CA7CEC-A1BA-4633-8EA1-2D36271BB62AQ34551046-2EC9BFFD-5BF4-48E4-8C3C-3850FEB8CEC6Q34603282-4E57F5D9-A749-4098-8CC7-BD498DB2B1D4Q34645985-B953BCF8-41CC-4B74-9836-772AFB876940Q34679298-583D584A-4E3C-4B25-96B9-106100C62BE2Q34707213-3144AC1B-DE3B-48E6-8D83-D3E45EB4BCABQ34992080-A645D345-DC1E-482B-A2EE-2688227921F4Q35007811-032A5218-3F2D-4D85-BD8B-814DC4C609C5Q35039727-0BD3B53F-22C8-40F6-B18A-773F3559BF6AQ35106033-04415F5F-457D-46C2-BD1E-6C3B9ECEB714Q35196702-DE2D9F16-34C2-4960-A7BA-12543CDA5883Q35740019-FF0A8866-AE12-4A1D-B893-86426AC5C509Q35781265-4F569C5E-DA67-46AD-875C-8472471801CAQ35797649-6C0A40C6-DAA9-44EE-99B9-4793C5AFCD48
P2860
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Early postinduction intensific ...... the Children's Oncology Group
@ast
Early postinduction intensific ...... the Children's Oncology Group
@en
type
label
Early postinduction intensific ...... the Children's Oncology Group
@ast
Early postinduction intensific ...... the Children's Oncology Group
@en
prefLabel
Early postinduction intensific ...... the Children's Oncology Group
@ast
Early postinduction intensific ...... the Children's Oncology Group
@en
P2093
P2860
P50
P1433
P1476
Early postinduction intensific ...... the Children's Oncology Group
@en
P2093
Allan F Pyesmany
Caroline A Hastings
Charles M Rubin
Cheryl Edens
Cynthia Delaat
David R Freyer
Harland N Sather
James B Nachman
Janet L Franklin
Kathy Bertolone
P2860
P304
P356
10.1182/BLOOD-2007-02-070342
P407
P577
2007-11-26T00:00:00Z